Lisdexamfetamine Dimesylate
These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Lisdexamfetamine Dimesylate capsules, for oral use, CII Initial U.S. Approval: 2007
2cedb4c2-1e40-4bc4-b9f4-127150c4afbd
HUMAN PRESCRIPTION DRUG LABEL
Oct 20, 2023
Lannett Company, Inc.
DUNS: 002277481
Products 7
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lisdexamfetamine Dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
Lisdexamfetamine Dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
Lisdexamfetamine Dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
Lisdexamfetamine Dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
Lisdexamfetamine Dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
Lisdexamfetamine Dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
Lisdexamfetamine Dimesylate
Product Details
FDA regulatory identification and product classification information